Heterozygous Deletion of Mitotic Arrest–Deficient Protein 1 (MAD1) Increases the Incidence of Tumors in Mice

Autor: Akiko Miyazato, Kerstin Haller, Yan Li, Yoichi Iwanaga, Kuan-Teh Jeang, Jerrold M. Ward, Jean-Marie Peloponese, Ya-Hui Chi, Robert Benezra, Sergey Sheleg
Přispěvatelé: Institut de Recherche en Infectiologie de Montpellier (IRIM), Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), Claremont Graduate University [Claremont, CA ], Molecular Virology Section, Laboratory of Molecular Microbiology, National Institutes of Health
Rok vydání: 2007
Předmět:
Zdroj: Cancer Research
Cancer Research, American Association for Cancer Research, 2007, 67 (1), pp.160-166. ⟨10.1158/0008-5472.CAN-06-3326⟩
ISSN: 1538-7445
0008-5472
DOI: 10.1158/0008-5472.can-06-3326
Popis: Mitotic arrest–deficient protein 1 (MAD1) is a component of the mitotic spindle assembly checkpoint. We have created a knockout mouse model to examine the physiologic consequence of reduced MAD1 function. Mad1+/− mice were successfully generated, but repeated paired mating of Mad1+/− with Mad1+/− mice failed to produce a single Mad1−/− animal, suggesting that the latter genotype is embryonic lethal. In aging studies conducted for >18 months, Mad1+/− mice compared with control wild-type (wt) littermates showed a 2-fold higher incidence of constitutive tumors. Moreover, 42% of Mad1+/− (P < 0.03), but 0% of wt, mice developed neoplasia after treatment with vincristine, a microtubule depolymerization agent. Mad1+/− mouse embryonic fibroblasts (MEF) were found to be more prone than wt cells to become aneuploid; Mad1+/−, but not wt, MEFs produced fibrosarcomas when explanted into nude mice. Our results indicate an essential MAD1 function in mouse development and correlate Mad1 haploinsufficiency with increased constitutive tumors. [Cancer Res 2007;67(1):160–6]
Databáze: OpenAIRE